In univariable Cox proportional hazards analysis, GLP-1RA use was associated with a lower hazard of the primary outcome compared with DPP-4i therapy (HR 0.75, 95% CI 0.600.94
Among patients with mild-to-moderate sloping hearing loss, the pitch of tonal tinnitus closely matched f_e with targeted training to reduce octave errors in pitch matching, likely explaining why earlier studies failed to establish this association
Doseresponse modeling confirmed that these benefits were obtained at relatively modest intakes: between 400 and 750 mg per day were sufficient to lower body weight, BMI, triglycerides, and fasting glucose
Now, a US-wide trial will test whether tirzepatide, the active ingredient in Zepbound, may be an effective treatment for people with long Covid
Semaglutide, the active ingredient in GLP-1 drugs, is protected in the U.S
N-acetylcysteine is a chemical reducer of disulfide bonds via its free sulfhydryl groups may interact with the extracellular disulfide bridges of angiotensin II receptor, alter its tertiary structure, and inhibit the binding of angiotensin II to its surface receptors (AT 1a receptors) with subsequent attenuation of signal transduction and cell action